Obesity pp 373-399 | Cite as

Surgical Approaches in the Treatment of Obesity

  • Phong Ching LeeEmail author
  • John B. Dixon
Reference work entry
Part of the Endocrinology book series (ENDOCR)


Bariatric-metabolic surgery is the most effective treatment option for clinically severe obesity that offers significant and durable weight loss. In this chapter, we examine the evidence for the common bariatric surgical procedures. We explore the mechanisms of action of surgery on weight loss and glycemic control, including changes in key hormones related to energy balance and glucose homeostasis. We discuss the role of the endocrinologist in helping decide the appropriate patients for bariatric-metabolic surgery and addressing non-surgical aspects of perioperative care, most notably nutritional and metabolic support. The acute post-surgical and longer-term nutritional and metabolic complications of surgery as well as recommendations for post-operative lifestyle, nutritional and comorbidity follow-up are also reviewed.


Bariatric surgery Metabolic surgery Weight loss Obesity 


  1. Andrews ZB. The extra-hypothalamic actions of ghrelin on neuronal function. Trends Neurosci. 2011;34(1):31–40.PubMedCrossRefGoogle Scholar
  2. Ba F, Siddiqi ZA. Neurologic complications of bariatric surgery. Rev Neurol Dis. 2010;7(4):119–24.PubMedGoogle Scholar
  3. Bal BS, Finelli FC, Shope TR, Koch TR. Nutritional deficiencies after bariatric surgery. Nat Rev Endocrinol. 2012;8(9):544–56.PubMedCrossRefGoogle Scholar
  4. Bazuin I, Pouwels S, Houterman S, Nienhuijs SW, Smulders JF, Boer AK. Improved and more effective algorithms to screen for nutrient deficiencies after bariatric surgery. Eur J Clin Nutr. 2017;71(2):198–202.PubMedCrossRefGoogle Scholar
  5. Becker DA, Balcer LJ, Galetta SL. The neurological complications of nutritional deficiency following bariatric surgery. J Obes. 2012;2012:608534.PubMedPubMedCentralCrossRefGoogle Scholar
  6. Bhatti JA, Nathens AB, Thiruchelvam D, Grantcharov T, Goldstein BI, Redelmeier DA. Self-harm emergencies after bariatric surgery: a population-based cohort study. JAMA Surg. 2016;151(3):226–32.PubMedCrossRefGoogle Scholar
  7. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724–37.PubMedCrossRefGoogle Scholar
  8. Campanha-Versiani L, Pereira DA, Ribeiro-Samora GA, Ramos AV, de Sander Diniz MF, De Marco LA, et al. The effect of a muscle weight-bearing and aerobic exercise program on the body composition, muscular strength, biochemical markers, and bone mass of obese patients who have undergone gastric bypass surgery. Obes Surg. 2017.Google Scholar
  9. Carlsson LM, Sjoholm K, Karlsson C, Jacobson P, Andersson-Assarsson JC, Svensson PA, et al. Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study. Lancet Diabetes Endocrinol. 2017;5(4):271–9.PubMedPubMedCentralCrossRefGoogle Scholar
  10. Chandarana K, Gelegen C, Karra E, Choudhury AI, Drew ME, Fauveau V, et al. Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY. Diabetes. 2011;60(3):810–8.PubMedPubMedCentralCrossRefGoogle Scholar
  11. Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012. JAMA Surg. 2014;149(3):275–87.PubMedPubMedCentralCrossRefGoogle Scholar
  12. Chondronikola M, Harris LL, Klein S. Bariatric surgery and type 2 diabetes: are there weight loss-independent therapeutic effects of upper gastrointestinal bypass? J Intern Med. 2016;280(5):476–86.PubMedPubMedCentralCrossRefGoogle Scholar
  13. Clements RH, Katasani VG, Palepu R, Leeth RR, Leath TD, Roy BP, et al. Incidence of vitamin deficiency after laparoscopic Roux-en-Y gastric bypass in a university hospital setting. Am Surg. 2006;72(12):1196–202. discussion 1203–1194PubMedGoogle Scholar
  14. Coleman KJ, Caparosa SL, Nichols JF, Fujioka K, Koebnick C, McCloskey KN, et al. Understanding the capacity for exercise in post-bariatric patients. Obes Surg. 2017;27(1):51–8.PubMedPubMedCentralCrossRefGoogle Scholar
  15. Colles SL, Dixon JB, Marks P, Strauss BJ, O’Brien PE. Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. Am J Clin Nutr. 2006;84(2):304–11.PubMedCrossRefGoogle Scholar
  16. Dargent J. Novel endoscopic management of obesity. Clin Endosc. 2016;49(1):30–6.PubMedPubMedCentralCrossRefGoogle Scholar
  17. Dixon JB. The effect of obesity on health outcomes. Mol Cell Endocrinol. 2010;316(2):104–8.PubMedCrossRefGoogle Scholar
  18. Dixon JB. Self-harm and suicide after bariatric surgery: time for action. Lancet Diabetes Endocrinol. 2016;4(3):199–200.PubMedCrossRefGoogle Scholar
  19. Dixon JB, Straznicky NE, Lambert EA, Schlaich MP, Lambert GW. Surgical approaches to the treatment of obesity. Nat Rev Gastroenterol Hepatol. 2011a;8(8):429–37.PubMedCrossRefGoogle Scholar
  20. Dixon JB, Zimmet P, Alberti KG, Rubino F, International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabet Med. 2011b;28(6):628–42.PubMedPubMedCentralCrossRefGoogle Scholar
  21. Dixon JB, Straznicky NE, Lambert EA, Schlaich MP, Lambert GW. Laparoscopic adjustable gastric banding and other devices for the management of obesity. Circulation. 2012;126(6):774–85.PubMedCrossRefGoogle Scholar
  22. Dixon JB, Hur KY, Lee WJ, Kim MJ, Chong K, Chen SC, et al. Gastric bypass in type 2 diabetes with BMI < 30: weight and weight loss have a major influence on outcomes. Diabet Med. 2013;30(4):e127–34.PubMedCrossRefGoogle Scholar
  23. Dixon JB, Lambert EA, Lambert GW. Neuroendocrine adaptations to bariatric surgery. Mol Cell Endocrinol. 2015;418(Pt 2):143–52.PubMedCrossRefGoogle Scholar
  24. Heber D, Greenway FL, Kaplan LM, Livingston E, Salvador J, Still C, et al. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(11):4823–43.PubMedCrossRefGoogle Scholar
  25. Holman RR. Assessing the potential for alpha-glucosidase inhibitors in prediabetic states. Diabetes Res Clin Pract. 1998;40 Suppl:S21–25.Google Scholar
  26. Ikramuddin S, Blackstone RP, Brancatisano A, Toouli J, Shah SN, Wolfe BM, et al. Effect of reversible intermittent intra-abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial. JAMA. 2014;312(9):915–22.PubMedCrossRefGoogle Scholar
  27. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129(25 Suppl 2):S102–38.PubMedCrossRefGoogle Scholar
  28. Jimenez A, Casamitjana R, Viaplana-Masclans J, Lacy A, Vidal J. GLP-1 action and glucose tolerance in subjects with remission of type 2 diabetes after gastric bypass surgery. Diabetes Care. 2013;36(7):2062–9.PubMedPubMedCentralCrossRefGoogle Scholar
  29. Jimenez A, Mari A, Casamitjana R, Lacy A, Ferrannini E, Vidal J. GLP-1 and glucose tolerance after sleeve gastrectomy in morbidly obese subjects with type 2 diabetes. Diabetes. 2014;63(10):3372–7.PubMedCrossRefGoogle Scholar
  30. Jorgensen NB, Dirksen C, Bojsen-Moller KN, Jacobsen SH, Worm D, Hansen DL, et al. Exaggerated glucagon-like peptide 1 response is important for improved beta-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes. Diabetes. 2013;62(9):3044–52.PubMedPubMedCentralCrossRefGoogle Scholar
  31. Kubik JF, Gill RS, Laffin M, Karmali S. The impact of bariatric surgery on psychological health. J Obes. 2013;2013:837989.PubMedPubMedCentralCrossRefGoogle Scholar
  32. Kwok CS, Pradhan A, Khan MA, Anderson SG, Keavney BD, Myint PK, et al. Bariatric surgery and its impact on cardiovascular disease and mortality: a systematic review and meta-analysis. Int J Cardiol. 2014;173(1):20–8.PubMedCrossRefGoogle Scholar
  33. Lalmohamed A, de Vries F, Bazelier MT, Cooper A, van Staa TP, Cooper C, et al. Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study. BMJ. 2012;345:e5085.PubMedPubMedCentralCrossRefGoogle Scholar
  34. Lee PC, Dixon J. Medical devices for the treatment of obesity. Nat Rev Gastroenterol Hepatol. 2017. doi:10.1038/nrgastro.2017.80.CrossRefGoogle Scholar
  35. Lee WJ, Almulaifi A, Chong K, Chen SC, Tsou JJ, Ser KH, et al. The effect and predictive score of gastric bypass and sleeve gastrectomy on type 2 diabetes mellitus patients with BMI <30 kg/m(2). Obes Surg. 2015;25(10):1772–8.PubMedCrossRefGoogle Scholar
  36. Livhits M, Mercado C, Yermilov I, Parikh JA, Dutson E, Mehran A, et al. Preoperative predictors of weight loss following bariatric surgery: systematic review. Obes Surg. 2012;22(1):70–89.PubMedCrossRefGoogle Scholar
  37. Look ARG. Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study. Obesity (Silver Spring). 2014;22(1):5–13.CrossRefGoogle Scholar
  38. Madsbad S, Holst JJ. GLP-1 as a mediator in the remission of type 2 diabetes after gastric bypass and sleeve gastrectomy surgery. Diabetes. 2014;63(10):3172–4.PubMedCrossRefGoogle Scholar
  39. Makinen J, Hannukainen JC, Karmi A, Immonen HM, Soinio M, Nelimarkka L, et al. Obesity-associated intestinal insulin resistance is ameliorated after bariatric surgery. Diabetologia. 2015;58(5):1055–62.PubMedPubMedCentralCrossRefGoogle Scholar
  40. Mastino D, Robert M, Betry C, Laville M, Gouillat C, Disse E. Bariatric surgery outcomes in Sarcopenic obesity. Obes Surg. 2016;26(10):2355–62.PubMedCrossRefGoogle Scholar
  41. Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, McMahon MM, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient – 2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring). 2013;21(Suppl 1):S1–27.CrossRefGoogle Scholar
  42. Mingrone G, Cummings DE. Changes of insulin sensitivity and secretion after bariatric/metabolic surgery. Surg Obes Relat Dis. 2016;12(6):1199–205.PubMedCrossRefGoogle Scholar
  43. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Nanni G, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015;386(9997):964–73.PubMedCrossRefGoogle Scholar
  44. Nakamura KM, Haglind EG, Clowes JA, Achenbach SJ, Atkinson EJ, Melton LJ 3rd, et al. Fracture risk following bariatric surgery: a population-based study. Osteoporos Int. 2014;25(1):151–8.PubMedCrossRefGoogle Scholar
  45. Nannipieri M, Mari A, Anselmino M, Baldi S, Barsotti E, Guarino D, et al. The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery. J Clin Endocrinol Metab. 2011;96(9):E1372–9.PubMedCrossRefGoogle Scholar
  46. Neff KJ, Olbers T, le Roux CW. Bariatric surgery: the challenges with candidate selection, individualizing treatment and clinical outcomes. BMC Med. 2013;11(1):8.PubMedPubMedCentralCrossRefGoogle Scholar
  47. Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol. 2017;14(3):160–9.PubMedCrossRefGoogle Scholar
  48. NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991;115(12):956–61.CrossRefGoogle Scholar
  49. Ponce J, DeMaria EJ, Nguyen NT, Hutter M, Sudan R, Morton JM. American Society for Metabolic and Bariatric Surgery estimation of bariatric surgery procedures in 2015 and surgeon workforce in the United States. Surg Obes Relat Dis. 2016;12(9):1637–9.PubMedCrossRefGoogle Scholar
  50. Pontiroli AE, Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg. 2011;253(3):484–7.PubMedCrossRefGoogle Scholar
  51. Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science. 2013;341(6150):1241214.PubMedPubMedCentralCrossRefGoogle Scholar
  52. Rogers CA, Welbourn R, Byrne J, Donovan JL, Reeves BC, Wordsworth S, et al. The By-Band study: gastric bypass or adjustable gastric band surgery to treat morbid obesity: study protocol for a multi-centre randomised controlled trial with an internal pilot phase. Trials. 2014;15:53.PubMedPubMedCentralCrossRefGoogle Scholar
  53. Rousseau C, Jean S, Gamache P, Lebel S, Mac-Way F, Biertho L, et al. Change in fracture risk and fracture pattern after bariatric surgery: nested case-control study. BMJ. 2016;354:i3794.PubMedPubMedCentralCrossRefGoogle Scholar
  54. Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG, Zimmet PZ, et al. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care. 2016;39(6):861–77.PubMedCrossRefGoogle Scholar
  55. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, et al. Bariatric surgery versus intensive medical therapy for diabetes – 3-year outcomes. N Engl J Med. 2014;370(21):2002–13.PubMedPubMedCentralCrossRefGoogle Scholar
  56. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, et al. Bariatric surgery versus intensive medical therapy for diabetes – 5-year outcomes. N Engl J Med. 2017;376(7):641–51.PubMedPubMedCentralCrossRefGoogle Scholar
  57. Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML, Lloyd RV. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med. 2005;353(3):249–54.PubMedCrossRefGoogle Scholar
  58. Shah M, Snell PG, Rao S, Adams-Huet B, Quittner C, Livingston EH, et al. High-volume exercise program in obese bariatric surgery patients: a randomized, controlled trial. Obesity (Silver Spring). 2011;19(9):1826–34.CrossRefGoogle Scholar
  59. Shah M, Law JH, Micheletto F, Sathananthan M, Dalla Man C, Cobelli C, et al. Contribution of endogenous glucagon-like peptide 1 to glucose metabolism after Roux-en-Y gastric bypass. Diabetes. 2014;63(2):483–93.PubMedPubMedCentralCrossRefGoogle Scholar
  60. Sjostrom L. Review of the key results from the Swedish obese subjects (SOS) trial – a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219–34.PubMedCrossRefGoogle Scholar
  61. Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A, et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med. 2011;365(17):1597–604.PubMedCrossRefGoogle Scholar
  62. Sweeney TE, Morton JM. Metabolic surgery: action via hormonal milieu changes, changes in bile acids or gut microbiota? A summary of the literature. Best Pract Res Clin Gastroenterol. 2014;28(4):727–40.PubMedPubMedCentralCrossRefGoogle Scholar
  63. Tarnoff M, Kaplan LM, Shikora S. An evidenced-based assessment of preoperative weight loss in bariatric surgery. Obes Surg. 2008;18(9):1059–61.PubMedCrossRefGoogle Scholar
  64. Tice JA, Karliner L, Walsh J, Petersen AJ, Feldman MD. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med. 2008;121(10):885–93.PubMedCrossRefGoogle Scholar
  65. Tremaroli V, Karlsson F, Werling M, Stahlman M, Kovatcheva-Datchary P, Olbers T, et al. Roux-en-Y gastric bypass and vertical banded Gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab. 2015;22(2):228–38.PubMedPubMedCentralCrossRefGoogle Scholar
  66. Welbourn R, Dixon J, Barth JH, Finer N, Hughes CA, le Roux CW, et al. NICE-accredited commissioning guidance for weight assessment and management clinics: a model for a specialist multidisciplinary team approach for people with severe obesity. Obes Surg. 2016;26(3):649–59.PubMedCrossRefGoogle Scholar
  67. Weng TC, Chang CH, Dong YH, Chang YC, Chuang LM. Anaemia and related nutrient deficiencies after Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis. BMJ Open. 2015;5(7):e006964.PubMedPubMedCentralCrossRefGoogle Scholar
  68. Wilson-Perez HE, Chambers AP, Ryan KK, Li B, Sandoval DA, Stoffers D, et al. Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like peptide 1 receptor deficiency. Diabetes. 2013;62(7):2380–5.PubMedPubMedCentralCrossRefGoogle Scholar
  69. Yen YC, Huang CK, Tai CM. Psychiatric aspects of bariatric surgery. Curr Opin Psychiatry. 2014;27(5):374–9.PubMedPubMedCentralCrossRefGoogle Scholar
  70. Yu EW. Bone metabolism after bariatric surgery. J Bone Miner Res. 2014;29(7):1507–18.PubMedPubMedCentralCrossRefGoogle Scholar
  71. Yu EW, Lee MP, Landon JE, Lindeman KG, Kim SC. Fracture risk after bariatric surgery: Roux-en-Y gastric bypass versus adjustable gastric banding. J Bone Miner Res. 2017;32(6):1229–36.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Obesity and Metabolism Unit, Department of EndocrinologySingapore General HospitalSingaporeSingapore
  2. 2.Clinical Obesity ResearchBaker Heart and Diabetes InstituteMelbourneAustralia

Personalised recommendations